High-grade lymphoma after azathioprine treatment for Vogt-Kaganayi-Harada syndrome

Leukemia and Lymphoma

Volumn 46, Issue 2, 2005, Pages 289-292

  Hon, Charmaine ^a   Ho, Shu Leong ^a   Ma, Edmond S K ^a   Trendell Smith, Nigel J ^a   Au, Wing Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Azathioprine; Lymphoma; Vogt Kaganayi Harada (VKH) syndrome

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; EPIRUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; ASEPTIC MENINGITIS; B CELL LYMPHOMA; BONE MARROW BIOPSY; CARCINOGENICITY; CASE REPORT; CHINESE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRANIAL NERVE PARALYSIS; DISSEMINATED CANCER; HLA MATCHING; HUMAN; LUMBAR PUNCTURE; LYMPH NODE BIOPSY; LYMPHATIC SYSTEM; MALE; NONHODGKIN LYMPHOMA; OPHTHALMOSCOPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; UVEITIS; VOGT KOYANAGI SYNDROME;

ADULT; AZATHIOPRINE; CARCINOGENS; CRANIAL NERVE DISEASES; HUMANS; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, HIGH-GRADE; MALE; UVEITIS; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 13244255333     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190400015634     Document Type: Article

References (22)

1. Kojima M, Nakamura S, Futamura N, Kurabayashi Y, Ban S, Itoh H, et al. Malignant lymphoma in patients with rheumatic diseases other than Sjogren's syndrome: a clinicopathologic study of five cases and a review of the Japanese literature. Jpn J Clin Once 1997;27(2):84-90.
2. Up Y, Irenic PH. Systemic lupus erythematosus and B-cell hematologic neoplasm. Lupus 2001;10(12):841-850.
3. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131(5):647-652.
4. Liang R, Chan D, Kwong YL, Chan V. Molecular detection of minimal residual disease for patients with leukaemia and lymphoma. Hong Kong Med J 1997;3(2):195-200.
5. Gocho K, Kondo I, Yamaki K. Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 2001;42(9):2004-2009.
6. Islam SM, Numaga J, Fujino Y, Hirata R, Matsuki K, Maeda H, et al. HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 1994;35(11):3890-3896.
7. Rutzen AR, Ortega-Larrocea G, Schwab IR, Rao NA. Simultaneous onset of Vogt-Koyanagi-Harada syndrome in monozygotic twins. Am J Ophthalmol 1995;119(2):239-240.
8. Read RW. Vogt-Koyanagi-Harada disease. Ophthalmol Clin North Am 2002;15(3):333-341, vii.
9. Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001;131(5):599-606.
10. Federman DG, Kravetz JD, Ruser CB, Judson PH, Kirsner RS. Vogt-Koyanagi-Harada syndrome and ulcerative colitis. South Med J 2004;97(2):169-171.
11. Najman-Vainer J, Levinson RD, Graves MC, Nguyen BT, Engstrom RE jr, Holland GN. An association between Vogt-Koyanagi-Harada disease and Guillain-Barre syndrome. Am J Ophthalmol 2001;131(5):615-619.
12. Maruyama Y, Hayashi H, Takahashi K, Iino K, Kora Y. A case of insulin dependent diabetes mellitus following systemic treatment for Vogt-Koyanagi-Harada syndrome. Ophthalmic Surg Lasers 2000;31(6):487-490.
13. Jovic NS, Nesovic M, Vranjesevic DN, Ciric J, Marinkovic DM, Bonaci B. The Vogt-Koyanagi-Harada syndrome: association with autoimmune polyglandular syndrome type 1. Postgrad Med J 1996;72(850):495-497.
14. Chuah SY, Lyne AJ, Dronfield MW. Vogt-Koyanagi-Harada syndrome, a rare association of Hodgkin's disease. Postgrad Med J 1991;67(787):476-478.
15. Cipriani D, Landonio G, Canepari C. A case of Vogt-Koyanagi-Harada syndrome in a patient affected by Hodgkin's disease. J Neurol 1989;236(5):303-304.
16. Walker J, Ober RR, Khan A, Yuen D, Rao NA. Intraocular lymphoma developing in a patient with Vogt-Koyanagi-Harada syndrome. Int Ophthalmol 1993;17(6):331-336.
17. Sylvestre DL, Disston AR, Bui DP. Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy. J Viral Hepat 2003;10(6):467-470.
18. Pettitt AR, Neoh C, Wong SH, Clark RE. Vogt-Koyanagi-Harada syndrome complicating allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;13(2):225-227.
19. Yato H, Matsumoto Y. CD56+ T cells in the peripheral blood of uveitis patients. Br J Ophthalmol 1999;83(12):1386-1388.
20. Jaffe ES, Harris NL, Stein H, Vardiman JWe. Chapter 9: Immunodeficiency associated lymphoproliferative disorders. World Health Organization Classification of Tumors. Tumors of Haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. pp 251-271.
21. An WY, Fung A, Man C, Ma SK, Wan TS, Liang R, et al. Aberrant p15 gene promoter methylation in therapy-related myelodysplastic syndrome and acute myeloid leukaemia: clinicopathological and karyotypic associations. Br J Haematol 2003;120(6):1062-1065.
22. Leandro MJ, Isenberg DA. Rheumatic diseases and malignancy - is there an association? Scand J Rheumatol 2001;30(4):185-188.